Sublingual or subcutaneous immunotherapy for allergic rhinitis?

Journal of Allergy and Clinical Immunology

Volumn 137, Issue 2, 2016, Pages 339-349.e10

  Durham, Stephen R ^a   Penagos, Martin ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

Allergic rhinitis; immunotherapy; subcutaneous immunotherapy; sublingual immunotherapy

Indexed keywords

ANTIALLERGIC AGENT; IMMUNOMODULATING AGENT; ALLERGEN;

ADVERSE OUTCOME; ALLERGIC RHINITIS; COCHRANE LIBRARY; CONTROLLED CLINICAL TRIAL (TOPIC); DRUG EFFICACY; EVIDENCE BASED MEDICINE; HUMAN; META ANALYSIS (TOPIC); POLLEN ALLERGY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SUBCUTANEOUS IMMUNOTHERAPY; SUBLINGUAL IMMUNOTHERAPY; SYSTEMATIC REVIEW (TOPIC); ADVERSE EFFECTS; DESENSITIZATION; IMMUNOLOGY; META ANALYSIS; PROCEDURES; RHINITIS, ALLERGIC; SUBCUTANEOUS DRUG ADMINISTRATION; SUBLINGUAL DRUG ADMINISTRATION; TREATMENT OUTCOME;

ADMINISTRATION, SUBLINGUAL; ALLERGENS; DESENSITIZATION, IMMUNOLOGIC; HUMANS; INJECTIONS, SUBCUTANEOUS; RHINITIS, ALLERGIC; SUBLINGUAL IMMUNOTHERAPY; TREATMENT OUTCOME;

EID: 84957942056     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2015.12.1298     Document Type: Review

References (78)

1. J. Bousquet, N. Khaltaev, A.A. Cruz, J. Denburg, W.J. Fokkens, A. Togias, and et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen) Allergy 63 suppl 86 2008 8 160
2. L.M. Wheatley, and A. Togias Clinical practice. Allergic rhinitis N Engl J Med 372 2015 456 463
3. V. Bauchau, and S.R. Durham Prevalence and rate of diagnosis of allergic rhinitis in Europe Eur Respir J 24 2004 758 764
4. R. Shaaban, M. Zureik, D. Soussan, C. Neukirch, J. Heinrich, J. Sunyer, and et al. Rhinitis and onset of asthma: a longitudinal population-based study Lancet 372 2008 1049 1057
5. A.N. Greiner, P.W. Hellings, G. Rotiroti, and G.K. Scadding Allergic rhinitis Lancet 378 2011 2112 2122
6. S.R. Durham, W. Emminger, A. Kapp, G. Colombo, J.G. de Monchy, S. Rak, and et al. Long-term clinical efficacy in grass pollen-induced rhinoconjunctivitis after treatment with SQ-standardized grass allergy immunotherapy tablet J Allergy Clin Immunol 125 2010 131 138 e1-7
7. E.O. Meltzer, M.S. Blaiss, M.J. Derebery, T.A. Mahr, B.R. Gordon, K.K. Sheth, and et al. Burden of allergic rhinitis: results from the Pediatric Allergies in America survey J Allergy Clin Immunol 124 suppl 2009 S43 S70
8. P. White, H. Smith, N. Baker, W. Davis, and A. Frew Symptom control in patients with hay fever in UK general practice: how well are we doing and is there a need for allergen immunotherapy? Clin Exp Allergy 28 1998 266 270
9. M.A. Calderon, B. Alves, M. Jacobson, B. Hurwitz, A. Sheikh, and S. Durham Allergen injection immunotherapy for seasonal allergic rhinitis Cochrane Database Syst Rev 1 2007 CD001936
10. M.A. Calderon, M. Penagos, M. Lagos, I. Garcia-Nunez, V. Carr, A. Sheikh, and et al. Allergen injection immunotherapy for perennial allergic rhinitis Cochrane Database Syst Rev 2 2016 [In press]
11. R. Dahl, A. Kapp, G. Colombo, J.G. de Monchy, S. Rak, W. Emminger, and et al. Efficacy and safety of sublingual immunotherapy with grass allergen tablets for seasonal allergic rhinoconjunctivitis J Allergy Clin Immunol 118 2006 434 440
12. H. Malling, and J. Bousquet Subcutaneous immunotherapy for allergic rhinoconjunctivitis, allergic asthma, and prevention of allergic diseases R.F. Lockey, Allergens and allergen immunotherapy 5th ed. 2014 CRC Press Boca Raton (FL) 349 360
13. G.W. Canonica, L. Cox, R. Pawankar, C.E. Baena-Cagnani, M. Blaiss, S. Bonini, and et al. Sublingual immunotherapy: World Allergy Organization position paper 2013 update World Allergy Organ J 7 2014 6
14. M.A. Calderon, T.B. Casale, H.S. Nelson, and P. Demoly An evidence-based analysis of house dust mite allergen immunotherapy: a call for more rigorous clinical studies J Allergy Clin Immunol 132 2013 1322 1336
15. S.R. Durham, W. Emminger, A. Kapp, J.G. de Monchy, S. Rak, G.K. Scadding, and et al. SQ-standardized sublingual grass immunotherapy: confirmation of disease modification 2 years after 3 years of treatment in a randomized trial J Allergy Clin Immunol 129 2012 717 725.e5
16. A. Didier, M. Worm, F. Horak, G. Sussman, O. de Beaumont, M. Le Gall, and et al. Sustained 3-year efficacy of pre- and coseasonal 5-grass-pollen sublingual immunotherapy tablets in patients with grass pollen-induced rhinoconjunctivitis J Allergy Clin Immunol 128 2011 559 566
17. V.D. Rienzo, M. Minelli, A. Musarra, R. Sambugaro, S. Pecora, W.G. Canonica, and et al. Post-marketing survey on the safety of sublingual immunotherapy in children below the age of 5 years Clin Exp Allergy 35 2005 560 564
18. M.A. Calderón, F.E. Simons, H.J. Malling, R.F. Lockey, P. Moingeon, and P. Demoly Sublingual allergen immunotherapy: mode of action and its relationship with the safety profile Allergy 67 2012 302 311
19. M. Makatsori, G.W. Scadding, C. Lombardo, G. Bisoffi, E. Ridolo, S.R. Durham, and et al. Dropouts in sublingual allergen immunotherapy trials - a systematic review Allergy 69 2014 571 580
20. D. Vita, L. Caminiti, P. Ruggeri, and G.B. Pajno Sublingual immunotherapy: adherence based on timing and monitoring control visits Allergy 65 2010 668 669
21. S.R. Durham, S.M. Walker, E.M. Varga, M.R. Jacobson, F. O'Brien, W. Noble, and et al. Long-term clinical efficacy of grass-pollen immunotherapy N Engl J Med 341 1999 468 475
22. H. Ott, J. Sieber, R. Brehler, R. Fölster-Holst, A. Kapp, L. Klimek, and et al. Efficacy of grass pollen sublingual immunotherapy for three consecutive seasons and after cessation of treatment: the ECRIT study Allergy 64 2009 1394 1401
23. A. Didier, H.J. Malling, M. Worm, F. Horak, G. Sussman, M. Melac, and et al. Post-treatment efficacy of discontinuous treatment with 300IR 5-grass pollen sublingual tablet in adults with grass pollen-induced allergic rhinoconjunctivitis Clin Exp Allergy 43 2013 568 577
24. A. Didier, H.J. Malling, M. Worm, F. Horak, and G.L. Sussman Prolonged efficacy of the 300IR 5-grass pollen tablet up to 2 years after treatment cessation, as measured by a recommended daily combined score Clin Transl Allergy 5 2015 12
25. R.M. Naclerio, D. Proud, B. Moylan, S. Balcer, L. Freidhoff, A. Kagey-Sobotka, and et al. A double-blind study of the discontinuation of ragweed immunotherapy J Allergy Clin Immunol 100 1997 293 300
26. S.M. Walker, V.A. Varney, M. Gaga, M.R. Jacobson, and S.R. Durham Grass pollen immunotherapy: efficacy and safety during a 4-year follow-up study Allergy 50 1995 405 413
27. V.A. Varney, M. Gaga, A.J. Frew, V.R. Aber, A.B. Kay, and S.R. Durham Usefulness of immunotherapy in patients with severe summer hay fever uncontrolled by antiallergic drugs BMJ 302 1991 265 269
28. R. Ariano, A.M. Kroon, G. Augeri, G.W. Canonica, and G. Passalacqua Long-term treatment with allergoid immunotherapy with Parietaria. Clinical and immunologic effects in a randomized, controlled trial Allergy 54 1999 313 319
29. L. Jacobsen, B. Niggemann, S. Dreborg, H.A. Ferdousi, S. Halken, A. Høst, and et al. Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study Allergy 62 2007 943 948
30. A. Des Roches, L. Paradis, J.L. Menardo, S. Bouges, J.P. Daurés, and J. Bousquet Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. VI. Specific immunotherapy prevents the onset of new sensitizations in children J Allergy Clin Immunol 99 1997 450 453
31. G.B. Pajno, G. Barberio, F. De Luca, L. Morabito, and S. Parmiani Prevention of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy. A six-year follow-up study Clin Exp Allergy 31 2001 1392 1397
32. E. Novembre, E. Galli, F. Landi, C. Caffarelli, M. Pifferi, E. De Marco, and et al. Coseasonal sublingual immunotherapy reduces the development of asthma in children with allergic rhinoconjunctivitis J Allergy Clin Immunol 114 2004 851 857
33. E. Valovirta, A.K. Berstad, J. de Blic, A. Bufe, P. Eng, S. Halken, and et al. Design and recruitment for the GAP trial, investigating the preventive effect on asthma development of an SQ-standardized grass allergy immunotherapy tablet in children with grass pollen-induced allergic rhinoconjunctivitis Clin Ther 33 2011 1537 1546
34. A.J. Frew, R.J. Powell, C.J. Corrigan, and S.R. Durham UK Immunotherapy Study Group. Efficacy and safety of specific immunotherapy with SQ allergen extract in treatment-resistant seasonal allergic rhinoconjunctivitis J Allergy Clin Immunol 117 2006 319 325
35. L. Cox, D. Larenas-Linnemann, R.F. Lockey, and G. Passalacqua Speaking the same language: the World Allergy Organization Subcutaneous Immunotherapy Systemic Reaction Grading System J Allergy Clin Immunol 125 2010 569 574 e1-7
36. S. Radulovic, M.A. Calderon, D. Wilson, and S. Durham Sublingual immunotherapy for allergic rhinitis Cochrane Database Syst Rev 12 2010 CD002893
37. S. Radulovic, D. Wilson, M. Calderon, and S. Durham Systematic reviews of sublingual immunotherapy (SLIT) Allergy 66 2011 740 752
38. A. Yukselen, S.G. Kendirli, M. Yilmaz, D.U. Altintas, and G.B. Karakoc Effect of one-year subcutaneous and sublingual immunotherapy on clinical and laboratory parameters in children with rhinitis and asthma: a randomized, placebo-controlled, double-blind, double-dummy study Int Arch Allergy Immunol 157 2012 288 298
39. R. Tiwari, P.L. Bhalla, and M.B. Singh Evaluation of molecular basis of cross reactivity between rye and Bermuda grass pollen allergens Allergol Int 58 2009 557 564
40. B.E. Stanaland, E. Fernández-Caldas, C.M. Jacinto, W.L. Trudeau, and R.F. Lockey Positive nasal challenge responses to Blomia tropicalis J Allergy Clin Immunol 97 1996 1045 1049
41. J. Dretzke, A. Meadows, N. Novielli, A. Huissoon, A. Fry-Smith, and C. Meads Subcutaneous and sublingual immunotherapy for seasonal allergic rhinitis: a systematic review and indirect comparison J Allergy Clin Immunol 131 2013 1361 1366
42. S. Lin, N. Erekosima, C. Suarez-Cuervo, M. Ramanathan, J. Kim, D. Ward, and et al. Allergen-specific immunotherapy for the treatment of allergic rhinoconjunctivitis and/or asthma: Comparative effectiveness review 2013 Agency for Healthcare Research and Quality Rockville (MD)
43. D. Di Bona, A. Plaia, M.S. Leto-Barone, S. La Piana, and G. Di Lorenzo Efficacy of subcutaneous and sublingual immunotherapy with grass allergens for seasonal allergic rhinitis: a meta-analysis-based comparison J Allergy Clin Immunol 130 2012 1097 1107.e2
44. D. Di Bona, A. Plaia, M.S. Leto-Barone, S. La Piana, and G. Di Lorenzo Efficacy of grass pollen allergen sublingual immunotherapy tablets for seasonal allergic rhinoconjunctivitis: a systematic review and meta-analysis JAMA Intern Med 175 2015 1301 1309
45. H. Nelson, S. Cartier, F. Allen-Ramey, S. Lawton, and M.A. Calderon Network meta-analysis shows commercialized subcutaneous and sublingual grass products have comparable efficacy J Allergy Clin Immunol Pract 3 2015 256 266.e3
46. E.J. Mills, K. Thorlund, and J.P. Ioannidis Demystifying trial networks and network meta-analysis BMJ 346 2013 f2914
47. M.S. Khinchi, L.K. Poulsen, F. Carat, C. André, A.B. Hansen, and H.J. Malling Clinical efficacy of sublingual and subcutaneous birch pollen allergen-specific immunotherapy: a randomized, placebo-controlled, double-blind, double-dummy study Allergy 59 2004 45 53
48. T. Quirino, E. Iemoli, E. Siciliani, S. Parmiani, and F. Milazzo Sublingual versus injective immunotherapy in grass pollen allergic patients: a double blind (double dummy) study Clin Exp Allergy 26 1996 1253 1261
49. M.T. Ventura, A. Carretta, R.A. Tummolo, R. Buquicchio, A. Arsieni, and N. Murgia Clinical data and inflammation parameters in patients with cypress allergy treated with sublingual swallow therapy and subcutaneous immunotherapy Int J Immunopathol Pharmacol 22 2009 403 413
50. I. Piazza, and N. Bizzaro Humoral response to subcutaneous, oral, and nasal immunotherapy for allergic rhinitis due to Dermatophagoides pteronyssinus Ann Allergy 71 1993 461 469
51. P. Bernardis, M. Agnoletto, P. Puccinelli, S. Parmiani, and M. Pozzan Injective versus sublingual immunotherapy in Alternaria tenuis allergic patients J Investig Allergol Clin Immunol 6 1996 55 62
52. D. Mungan, Z. Misirligil, and L. Gürbüz Comparison of the efficacy of subcutaneous and sublingual immunotherapy in mite-sensitive patients with rhinitis and asthma - a placebo controlled study Ann Allergy Asthma Immunol 82 1999 485 490
53. R.E. Rossi, G. Monasterolo, G. Coco, L. Silvestro, and D. Operti Evaluation of serum IgG4 antibodies specific to grass pollen allergen components in the follow up of allergic patients undergoing subcutaneous and sublingual immunotherapy Vaccine 25 2007 957 964
54. M. Mauro, M. Russello, C. Incorvaia, G.B. Gazzola, G. Di Cara, and F. Frati Comparison of efficacy, safety and immunologic effects of subcutaneous and sublingual immunotherapy in birch pollinosis: a randomized study Eur Ann Allergy Clin Immunol 39 2007 119 122
55. J. Pokladnikova, I. Krcmova, and J. Vlcek Economic evaluation of sublingual vs subcutaneous allergen immunotherapy Ann Allergy Asthma Immunol 100 2008 482 489
56. C. Antúnez, C. Mayorga, J.L. Corzo, A. Jurado, and M.J. Torres Two year follow-up of immunological response in mite-allergic children treated with sublingual immunotherapy. Comparison with subcutaneous administration Pediatr Allergy Immunol 19 2008 210 218
57. R. Tahamiler, G. Saritzali, S. Canakcioglu, E. Ozcora, and A. Dirican Comparison of the long-term efficacy of subcutaneous and sublingual immunotherapies in perennial rhinitis ORL J Otorhinolaryngol Relat Spec 70 2008 144 150
58. A.O. Eifan, T. Akkoc, A. Yildiz, S. Keles, C. Ozdemir, N.N. Bahceciler, and et al. Clinical efficacy and immunological mechanisms of sublingual and subcutaneous immunotherapy in asthmatic/rhinitis children sensitized to house dust mite: an open randomized controlled trial Clin Exp Allergy 40 2010 922 932
59. S. Keles, E. Karakoc-Aydiner, A. Ozen, A.G. Izgi, A. Tevetoglu, T. Akkoc, and et al. A novel approach in allergen-specific immunotherapy: combination of sublingual and subcutaneous routes J Allergy Clin Immunol 128 2011 808 815.e7
60. K. Aasbjerg, K.P. Dalhoff, and V. Backer Adverse events during immunotherapy against grass pollen-induced allergic rhinitis - differences between subcutaneous and sublingual treatment Basic Clin Pharmacol Toxicol 117 2015 73 84
61. E. Karakoc-Aydiner, A. Eifan, S. Baris, E. Gunay, E. Akturk, T. Akkoc, and et al. Long-term effect of sublingual and subcutaneous immunotherapy in dust mite-allergic children with asthma/rhinitis: a 3-year prospective randomized controlled trial J Investig Allergol Clin Immunol 25 2015 334 342
62. E. Lee, M. Kim, S. Yang, J. Yu, and S. Hong Comparison of short-term effects between subcutaneous and sublingual immunotherapies in children with house dust mite-sensitized allergic rhinitis and asthma Allergy Asthma Respir Dis 3 2015 180 186
63. D. Saporta Efficacy of sublingual immunotherapy versus subcutaneous injection immunotherapy in allergic patients J Environ Public Health 2012 2012 492405
64. D. Saporta, and A.B. McDaniel Efficacy comparison of multiple-antigen subcutaneous injection immunotherapy and multiple-antigen sublingual immunotherapy Ear Nose Throat J 86 2007 493 497
65. H.S. Nelson Subcutaneous immunotherapy versus sublingual immunotherapy: which is more effective? J Allergy Clin Immunol Pract 2 2014 144 151
66. J.M. Kim, S.Y. Lin, C. Suarez-Cuervo, Y. Chelladurai, M. Ramanathan, J.B. Segal, and et al. Allergen-specific immunotherapy for pediatric asthma and rhinoconjunctivitis: a systematic review Pediatrics 131 2013 1155 1167
67. Y. Chelladurai, C. Suarez-Cuervo, N. Erekosima, J.M. Kim, M. Ramanathan, J.B. Segal, and et al. Effectiveness of subcutaneous versus sublingual immunotherapy for the treatment of allergic rhinoconjunctivitis and asthma: a systematic review J Allergy Clin Immunol Pract 1 2013 361 369
68. K.C. Bergmann, P. Demoly, M. Worm, W.J. Fokkens, T. Carrillo, A.I. Tabar, and et al. Efficacy and safety of sublingual tablets of house dust mite allergen extracts in adults with allergic rhinitis J Allergy Clin Immunol 133 2014 1608 1614.e6
69. H. Mosbech, G.W. Canonica, V. Backer, F. de Blay, L. Klimek, L. Broge, and et al. SQ house dust mite sublingually administered immunotherapy tablet (ALK) improves allergic rhinitis in patients with house dust mite allergic asthma and rhinitis symptoms Ann Allergy Asthma Immunol 114 2015 134 140
70. P. Demoly, W. Emminger, D. Rehm, V. Backer, L. Tommerup, and J. Kleine-Tebbe Effective treatment of house dust mite-induced allergic rhinitis with 2 doses of the SQ HDM SLIT-tablet: results from a randomized double-blind, placebo-controlled phase III trial J Allergy Clin Immunol 137 2016 444 451
71. Y. Okamoto, K. Okubo, S. Yonekura, K. Hashiguchi, M. Goto, T. Otsuka, and et al. Efficacy and safety of sublingual immunotherapy for two seasons in patients with Japanese cedar pollinosis Int Arch Allergy Immunol 166 2015 177 188
72. J. Maloney, D.I. Bernstein, H. Nelson, P. Creticos, J. Hébert, M. Noonan, and et al. Efficacy and safety of grass sublingual immunotherapy tablet, MK-7243: a large randomized controlled trial Ann Allergy Asthma Immunol 112 2014 146 153.e2
73. J. Maloney, B.M. Prenner, D.I. Bernstein, S. Lu, S. Gawchik, G. Berman, and et al. Safety of house dust mite sublingual immunotherapy standardized quality tablet in children allergic to house dust mites Ann Allergy Asthma Immunol 2015 [Epub ahead of print]
74. G.W. Canonica, C.E. Baena-Cagnani, J. Bousquet, P.J. Bousquet, R.F. Lockey, H.J. Malling, and et al. Recommendations for standardization of clinical trials with allergen specific immunotherapy for respiratory allergy. A statement of a World Allergy Organization (WAO) taskforce Allergy 62 2007 317 324
75. P.J. Bousquet, J. Brozek, C. Bachert, T. Bieber, S. Bonini, P. Burney, and et al. The CONSORT statement checklist in allergen-specific immunotherapy: a GA2LEN paper Allergy 64 2009 1737 1745
76. L. Cox, H. Nelson, R. Lockey, C. Calabria, T. Chacko, I. Finegold, and et al. Allergen immunotherapy: a practice parameter third update J Allergy Clin Immunol 127 suppl 2011 S1 S55
77. O. Pfaar, P. Demoly, R. Gerth van Wijk, S. Bonini, J. Bousquet, G.W. Canonica, and et al. Recommendations for the standardization of clinical outcomes used in allergen immunotherapy trials for allergic rhinoconjunctivitis: an EAACI Position Paper Allergy 69 2014 854 867
78. G. Passalacqua, C.E. Baena-Cagnani, J. Bousquet, G.W. Canonica, T.B. Casale, L. Cox, and et al. Grading local side effects of sublingual immunotherapy for respiratory allergy: speaking the same language J Allergy Clin Immunol 132 2013 93 98